{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001438569","name":"Grifols SA","summary":"Grifols S.A. is a vertically integrated global producer of plasma derivative therapeutics, founded in 1940 in Barcelona, Spain. The company collects plasma, manufactures protein-based therapies including immunoglobulins, albumin, A1PI, and clotting factors, and distributes them to healthcare providers in over 100 countries. It also develops in vitro diagnostics products, analytical instruments, reagents, and hospital infusion and nutrition solutions.","people":[],"products":[{"name":"Immunoglobulins (IG)","type":"platform","description":"Plasma-derived protein therapies for immune deficiencies and immune-mediated conditions."},{"name":"Albumin","type":"platform","description":"Plasma-derived protein used for severe burns, shock, and other critical conditions."},{"name":"Alpha-1 Proteinase Inhibitor (A1PI)","type":"platform","description":"Plasma-derived therapy for A1PI deficiency and related emphysema."},{"name":"Clotting Factors","type":"platform","description":"Plasma-derived therapies for hemophilia A and B and von Willebrand disease."},{"name":"In Vitro Diagnostics Products","type":"hardware","description":"Analytical instruments, reagents, and software for clinical and blood bank laboratories."},{"name":"Infusion Solutions and Nutrition Products","type":"service","description":"Hospital infusion solutions, nutrition products, and medical devices for clinics and hospitals."},{"name":"Nucleic Acid Testing (NAT) Donor Screening","type":"platform","description":"Donor screening diagnostics acquired from Hologic in 2017."}],"partnerships":[{"partner_name":"Egypt's National Services Projects Organization (NSPO)","partnership_type":"strategic","description":"Joint venture operating plasma collection centers in Egypt.","start_date":null},{"partner_name":"GIC Private Limited (Parette Investment Pte. Ltd.)","partnership_type":"strategic","description":"GIC acquired preferred shares representing 12.9% of Biomat Newco and 12.5% of Biomat USA for $990 million.","start_date":null},{"partner_name":"ImmunoTek GH, LLC","partnership_type":"strategic","description":"Joint operation (Biotek America LLC) for construction and acquisition of 28 plasma collection centers in the U.S.","start_date":null},{"partner_name":"Shanghai RAAS Blood Products Co Ltd","partnership_type":"strategic","description":"Grifols held equity stake in Shanghai RAAS; sold 20% stake to Haier group in 2024 for ~$1.8 billion.","start_date":null},{"partner_name":"Haier Group","partnership_type":"strategic","description":"Purchased Grifols' 20% equity stake in Shanghai RAAS for approximately $1.8 billion in June 2024.","start_date":null}],"affiliations":[],"origin":{"leaf":"d3867c00c2785ca7026514cc5665ccb2aa32309cd69566f169adced430b4767c","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"6b0e74c76f812a98fa9ea53be9ae7450cae6edb59533822178317ca46a7d488d","parent":"c8fa4c73311b7a3f6c23e073819b2b8c3d6e5e0369cf945b706f730c27116f71","source":"0001104659-25-034245","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}